The effects of growth hormone deficiency and growth hormone replacement therapy on bone: A meeting report

Hormone Research

Volumn 54, Issue SUPPL. 1, 2000, Pages 68-74

  Cowell, Christopher T ^a   Wüster, Christian ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

BONE METABOLISM; BONE STRENGTH; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DRUG EFFECT; EVIDENCE BASED MEDICINE; FRACTURE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; ITALY; PRIORITY JOURNAL; VOLUMETRY;

EID: 0034526280     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053301     Document Type: Conference Paper

References (45)

1. Erhöhte Prävalenz von osteoporose und arteriosklerose bei konventionell substituierter hypophysenvorderlappeninsuffizienz: Bedarf einer zusätzlichen wachtumshormonsubstitution?
2. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency
3. The influence of growth hormone (GH) deficiency, GH replacement therapy and other aspects of hypopituitarism on fracture rate and bone mineral density
4. Prediction of fracture risk using axial bone mineral density in a perimenopausal population: A prospective study
5. Antifracture efficacy of antiresorptive agents are related to changes in bone density
6. Bone mineral content of spine and forearm in osteoporosis and in German normals: Influences of sex, age and anthropometric parameters
7. Bone mineral density of total body, spine, and femoral neck in children and young adults: A cross-sectional and longitudinal study
8. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper
9. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology
10. Universal standardization of bone density measurements: A method with optimal properties for calibration among several instruments
11. Assessment of bone architecture with ultrasonometry: Experimental and clinical experience
12. Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study
13. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: A prospective study
14. Prediction of fracture risk by radiographic absorptiometry and quantitative ultrasound: A prospective study
15. Quantitative ultrasound of the calcaneus reflects the material properties of calcaneal trabecular bone
16. Phalangeal Osteosonogrammetry Study (PHOS): Age related changes, diagnostic sensitivity and discrimination power
17. Advanced imaging of the macrostructure and microstructure of bone
18. Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography
19. Proton magnetic resonance microimaging of human trabecular bone
20. Bone mineral density and biochemical parameters of bone turnover in children with growth hormone deficiency
21. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults
22. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency
23. Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: An interim report
24. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass
25. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency
26. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency
27. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I
28. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
29. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I and IGF binding protein 3
30. Reduced bone mineral content in adult patients with growth hormone deficiency
31. Consequences of childhood-onset growth hormone deficiency for adult bone mass
32. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover
33. Reduced bone mineral density in patients with adult onset growth hormone deficiency
34. Fracture rates in patients with growth hormone deficiency
35. The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men
36. Growth hormone, insulin-like growth factors - Potential applications and limitations in the management of osteoporosis
37. Long-term effects of growth hormone treatment on bone density
38. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults
39. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short- or long-term GH replacement therapy
40. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis
41. Why do bone strength and 'mass' in aging adults become unresponsive to vigorous exercise? Insights of the Utah paradigm
42. Ageing and growth hormone status
43. Growth hormone treatment of osteoporotic postmenopausal women - A one-year placebo-controlled study
44. Is there a role for GH therapy in osteoporosis and ageing?
45. Decreased serum levels of insulin-like growth factors 1 and 2 and IGF binding protein-3 in patients with osteoporosis